serena williams glp-1 commercial is in a new ad campaign for weight loss medication (GLP-1 from Ro), but this is a complex story with two very different sides. Is this a brave move to normalize the medication or a Serena Williams weight loss drug:

Given the fact that SGLT2i and GLP1RA safely reduce HbA1c without increased risk of hypoglycemia or weight gain and have beneficial cardiorenal effects across a broad range of subjects with T2DM, we believe these agents should be considered regardless of the presence of CVD

Beta class, Fosfomycin resistance proteins, Xi class and Ure2 proteins [48]

Our high-quality L-carnitine supplement from BodyPlanet is carefully formulated to optimally complement your daily diet

has received consultancy and/or lecture fees from companies with an interest in developing and marketing incretin-based therapies for treatment of type 2 diabetes mellitus (Boehringer Ingelheim, Lilly, Merck/MSD and Novo Nordisk)